Kenneth G. Russell

Basel, BS 4070, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice.

Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice.

Journal: Current oncology (Toronto, Ont.)

Published: June 14, 2021

High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer.

High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer.

Journal: Molecular oncology

Published: July 06, 2020

Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?

Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?

Journal: Journal of cancer research and clinical oncology

Published: August 05, 2019

Polyunsaturated fatty acid food frequency questionnaire validation in people with end stage renal disease on dialysis.

Polyunsaturated fatty acid food frequency questionnaire validation in people with end stage renal disease on dialysis.

Journal: Nutrition & dietetics : the journal of the Dietitians Association of Australia

Published: April 19, 2018

Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.

Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.

Journal: Targeted oncology

Published: January 22, 2018

Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients.

Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients.

Journal: Gynecologic oncology

Published: August 08, 2017

Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project.

Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project.

Journal: Genes & cancer

Published: January 05, 2017

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 04, 2016

Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.

Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.

Journal: BioMed research international

Published: December 17, 2014

A practical approach to aid physician interpretation of clinically actionable predictive biomarker results in a multi-platform tumor profiling service.

A practical approach to aid physician interpretation of clinically actionable predictive biomarker results in a multi-platform tumor profiling service.

Journal: Frontiers in pharmacology

Published: February 06, 2014

Assessing long-chain ω-3 polyunsaturated fatty acids: a tailored food-frequency questionnaire is better.

Assessing long-chain ω-3 polyunsaturated fatty acids: a tailored food-frequency questionnaire is better.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: September 26, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026